欧盟EMA药品数据库-欧盟集中审批药品（European Medicines Agency Authorisation of Medicines DataBase）

商品名称	适用类别	通用名称	活性成分	产品号	上市许可开发者/申请人/持有人	上市许可日期	许可状态
Stoboclo	Human	denosumab	denosumab	EMEA/H/C/006156	Celltrion Healthcare Hungary Kft.	2025/02/14	Authorised
Osenvelt	Human	denosumab	denosumab	EMEA/H/C/006157	Celltrion Healthcare Hungary Kft.	2025/02/14	Authorised
Obodence	Human	denosumab	denosumab	EMEA/H/C/006424	Samsung Bioepis NL B.V.	2025/02/12	Authorised
Xbryk	Human	denosumab	denosumab	EMEA/H/C/006468	Samsung Bioepis NL B.V.	2025/02/12	Authorised
Wyost	Human	denosumab	denosumab	EMEA/H/C/006378	Sandoz GmbH	2024/05/17	Authorised
Jubbonti	Human	denosumab	denosumab	EMEA/H/C/005964	Sandoz GmbH	2024/05/16	Authorised
Xgeva	Human	denosumab	denosumab	EMEA/H/C/002173	Amgen Europe B.V.	2011/07/13	Authorised
Prolia	Human	denosumab	denosumab	EMEA/H/C/001120	Amgen Europe B.V.	2010/05/26	Authorised
Osqay	Human	denosumab	denosumab	EMEA/H/C/006492	Theramex Ireland Limited		Opinion
Acvybra	Human	denosumab	denosumab	EMEA/H/C/006734	Reddy Holding GmbH		Opinion
Xbonzy	Human	denosumab	denosumab	EMEA/H/C/006722	Reddy Holding GmbH		Opinion

商品名称Name of medicine	*示例：Zokinvy（英文）
药品通用名或非专利名称International non-proprietary name (INN) / common name	*示例：lonafarnib（英文）
活性成分Active substance	*示例：lonafarnib（英文）
产品号EMA product number	*示例：EMEA/H/C/005271
ATC编号ATC code	*示例：L01EA06
上市许可开发者/申请人/持有人Marketing authorisation developer / applicant / holder	*示例：Janssen
药物治疗学分组Pharmacotherapeutic group	*示例：Antineoplastic
适应症Therapeutic indication	*示例：leukaemia
许可状态Medicine status
上市许可日期Marketing authorisation date	-